Recent research has demonstrated the involvement of FCER1G in the pathogenesis of various diseases, including glioma [58], diabetic kidney disease [59], endometrial cancer [60], COVID-19 [61], and osteosarcoma [62]. This evidence concerns the gene FCER1G and diabetic kidney disease.